Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 2 Scores of SSRS, FACT-L, CD-RISC- 10, FHI, and medical expenses for lung cancer patients (N = 421)

From: Potential profile analysis of financial toxicity and its related factors among lung cancer patients

Variables

(Mean ± SD)/M (Q1,Q3)

COST-PROM

16 (9,24)

FACT-L

79.08 ± 19.185

PWB

17 (13,21)

SWB

15 (12,18)

EWB

14 (7,19)

FWB

10 (7,15)

ACL

24 (19,28)

SSRS

31 (28,35)

Subjective Support

10 (8,11)

Objective Support

16 (14,19)

Utilization of Social support

5 (4,7)

CD-RISC- 10

19 (11,26)

Total Hospital Expenses (yuan)

68000 (30000160000)

Out-of-Pocket Expenses (yuan)

15000 (330030000)

Cost of Outsourcing Drugs (yuan)

2000 (022500)

Board and Lodging Expenses (yuan)

4000 (1500,8100)

Total Transportation Cost (yuan)

2000 (800,5600)

Total Nutrition Cost (yuan)

30 (0,4250)